Empiric Antibiotic Treatment for Septic Patients in the Intensive Care Unit

Recruiting Observational Study
Septic Patients Admitted to the ICU
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 99
Sex
Any
Study type
Observational
Participants needed
155 (estimated)
Sponsor
Meir Medical Center · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Sepsis is one of the most common causes of ICU admission. About 5-15% of patients admitted to the hospital with an infection will have sepsis, and about 30-40% of them will have septic shock. About 34% of septic patients and about 53% of patients with septic shock will die within 28 days of admission. Broad-spectrum empiric antibiotic treatment (depending on the source of infection and patient ris…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * All patients admitted to the general ICU due to sepsis or septic shock between 1/1/20 and 31/12/20 Exclusion Criteria: Patients who were admitted due to other non-infectious etiologies \-
Contacts

No contact information available.